Identification and Preclinical Evaluation of SC144, a Novel Pyrroloquinoxaline Derivative with Broad-Spectrum Anticancer Activity

Publisher: Bentham Science Publishers

E-ISSN: 1875-5607|16|8|644-650

ISSN: 1389-5575

Source: Mini Reviews in Medicinal Chemistry, Vol.16, Iss.8, 2016-05, pp. : 644-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract